{"count": 2, "results": [{"_id": "9888646", "pmid": 9888646, "title": "Effects of fibric acid derivatives and metformin on postprandial lipemia.", "journal": "Atherosclerosis", "authors": ["Weintraub MS", "Charach G", "Grosskopf I"], "date": "1998-12-01T00:00:00Z", "doi": "10.1016/s0021-9150(98)00221-4", "meta_date_publication": "1998 Dec", "meta_volume": "141 Suppl 1", "meta_issue": "", "meta_pages": "S71-5", "score": 50067.96, "text_hl": "In conclusion @CHEMICAL_Gemfibrozil @CHEMICAL_MESH:D015248 @@@gemfibrozil@@@, @CHEMICAL_Bezafibrate @CHEMICAL_MESH:D001629 @@@bezafibrate@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ were shown to be beneficial in the clearance of @GENE_PPL @GENE_5493 @@@PPLp@@@ in @<m>DISEASE_Hypertriglyceridemic_Waist</m> @DISEASE_MESH:D064250 @@@hypertriglyceridemic@@@ @SPECIES_9606 @@@patients@@@, subjects with isolated low HDL-C levels and nondiabetic @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ intolerant subjects, respectively.", "citations": {"NLM": "Weintraub MS, Charach G, Grosskopf I. Effects of fibric acid derivatives and metformin on postprandial lipemia. Atherosclerosis. 1998 Dec;141 Suppl 1():S71-5. PMID: 9888646", "BibTeX": "@article{9888646, title={Effects of fibric acid derivatives and metformin on postprandial lipemia.}, author={Weintraub MS and Charach G and Grosskopf I}, journal={Atherosclerosis}, volume={141 Suppl 1}, pages={S71-5}}"}}, {"_id": "8364001", "pmid": 8364001, "title": "Pharmacological control of hypertriglyceridemia.", "journal": "Cardiovasc Drugs Ther", "authors": ["Franceschini G", "Paoletti R"], "date": "1993-06-01T00:00:00Z", "doi": "10.1007/BF00880152", "meta_date_publication": "1993 Jun", "meta_volume": "7", "meta_issue": "3", "meta_pages": "297-302", "score": 50038.836, "text_hl": "@CHEMICAL_fibric_acid @CHEMICAL_MESH:C010285 @@@Fibric acid@@@ derivatives and @CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@nicotinic acid@@@ (and its derivatives) are the drugs of choice when treating @<m>DISEASE_Hypertriglyceridemic_Waist</m> @DISEASE_MESH:D064250 @@@hypertriglyceridemic@@@ @SPECIES_9606 @@@patients@@@; @CHEMICAL_Fatty_Acids_Omega_3 @CHEMICAL_MESH:D015525 @@@n-3 fatty acids@@@ (@CHEMICAL_Fish_Oils @CHEMICAL_MESH:D005395 @@@fish oil@@@) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (especially in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@) represent additional therapeutic agents.", "citations": {"NLM": "Franceschini G, Paoletti R. Pharmacological control of hypertriglyceridemia. Cardiovasc Drugs Ther. 1993 Jun;7(3):297-302. PMID: 8364001", "BibTeX": "@article{8364001, title={Pharmacological control of hypertriglyceridemia.}, author={Franceschini G and Paoletti R}, journal={Cardiovasc Drugs Ther}, volume={7}, number={3}, pages={297-302}}"}}]}